These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5105219)

  • 21. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
    Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.
    Varga L; Lutterbeck PM; Pryor JS; Wenner R; Erb H
    Br Med J; 1972 Jun; 2(5816):743-4. PubMed ID: 4556543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by 2-Br alpha-ergocryptine-mesilate (CB-154) of suckling-induced pituitary prolactin depletion in lactating rats.
    Flückiger E; Kovacs E
    Experientia; 1974 Oct; 30(10):1173. PubMed ID: 4435126
    [No Abstract]   [Full Text] [Related]  

  • 24. Galactorrhoea following hypophysectomy in a boy with a prolactinoma.
    Dandona P; Mohiuddin J; Lindsay KW
    Postgrad Med J; 1984 Aug; 60(706):540-1. PubMed ID: 6540876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases].
    Hartemann P; Leclere J; Groussin M; Valdenaire JC; Maureira JJ; Belleville F; Nabet P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Jun; 6(4):537-46. PubMed ID: 915214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of lactation with a new ergot derivative, CB-154. Comparison with ablacton].
    Mendes ML
    Brux Med; 1974 Dec; 54(12):737-41. PubMed ID: 4474051
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of galactorrhea.
    Flückiger E; Saameli K; Daughaday WH
    N Engl J Med; 1972 Mar; 286(10):547. PubMed ID: 5062079
    [No Abstract]   [Full Text] [Related]  

  • 28. [Parlodel in lactation mastitis].
    Dolzhikov AL; Kliachkin ML
    Sov Med; 1986; (8):115-6. PubMed ID: 3775505
    [No Abstract]   [Full Text] [Related]  

  • 29. Successufl ovulation and pregnancy achieved by cb-154 (2-br-alpha-ergocryptine) in a woman with Chiari-Frommel syndrome.
    Seki K; Seki M
    J Clin Endocrinol Metab; 1974 Mar; 38(3):598-9. PubMed ID: 4815181
    [No Abstract]   [Full Text] [Related]  

  • 30. [Galactorrhea in the woman].
    Leutenegger M; Audibert A; Caron J; Renard A
    Schweiz Rundsch Med Prax; 1972 Jun; 61(23):762-6. PubMed ID: 4672085
    [No Abstract]   [Full Text] [Related]  

  • 31. Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.
    Del Pozo E; Friesen H; Burmeister P
    Schweiz Med Wochenschr; 1973 Jun; 103(23):847-8. PubMed ID: 4351250
    [No Abstract]   [Full Text] [Related]  

  • 32. ["Use of bromocriptin (CB 154) in the treatment of puerperal and pathological lactation" (author's transl)].
    del Pozo E
    Schweiz Rundsch Med Prax; 1976 Feb; 65(7):181-5. PubMed ID: 1250831
    [No Abstract]   [Full Text] [Related]  

  • 33. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)].
    Rezábek K; Ausková M; Semonský M
    Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bromocriptine treatment of infertile women with amenorrhoea--galactorrhoea].
    Nillius SJ; Skarin O
    Lakartidningen; 1977 Nov; 74(46):4110-2. PubMed ID: 926944
    [No Abstract]   [Full Text] [Related]  

  • 35. The 'Alice in Wonderland' experience. Ergot alkaloid therapy for prolactin-secreting pituitary tumors.
    Williams RC; Sherman C; Buckman MT
    West J Med; 1983 Mar; 138(3):391-7. PubMed ID: 6858128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ergotism: a possible etiology for puerperal psychosis.
    Iffy L; Lindenthal JJ; McArdle JJ; McNamara RE; Szodi Z; Ganesh V
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):475-7. PubMed ID: 2915878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levodopa suppression of prolactin in nonpuerperal galactorrhea.
    Malarkey WB; Jacobs LS; Daughaday WH
    N Engl J Med; 1971 Nov; 285(21):1160-3. PubMed ID: 5107027
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dopaminergic ergot combinations. A new therapeutic principle].
    von Werder K
    MMW Munch Med Wochenschr; 1983 Jun; 125(23):489-91. PubMed ID: 6410211
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pituitary adenomas (prolactinomas) and amenorrhea-galactorrhea].
    van der Merwe JV
    S Afr Med J; 1981 Jan; 59(5):137-40. PubMed ID: 7006109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galactorrhoea, hyperprolactinaemia, and pituitary adenoma presenting during metoclopramide therapy.
    Cooper BT; Mountford RA; McKee C
    Postgrad Med J; 1982 May; 58(679):314-5. PubMed ID: 7202198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.